ATE328613T1 - Modifizierte therapeutische mittel - Google Patents
Modifizierte therapeutische mittelInfo
- Publication number
- ATE328613T1 ATE328613T1 AT03793901T AT03793901T ATE328613T1 AT E328613 T1 ATE328613 T1 AT E328613T1 AT 03793901 T AT03793901 T AT 03793901T AT 03793901 T AT03793901 T AT 03793901T AT E328613 T1 ATE328613 T1 AT E328613T1
- Authority
- AT
- Austria
- Prior art keywords
- elements
- agent
- modified therapeutic
- therapeutic agents
- modified
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 239000012528 membrane Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 239000000823 artificial membrane Substances 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 abstract 1
- 210000003722 extracellular fluid Anatomy 0.000 abstract 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0220936.9A GB0220936D0 (en) | 2002-09-05 | 2002-09-05 | Modified therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE328613T1 true ATE328613T1 (de) | 2006-06-15 |
Family
ID=9943766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03793901T ATE328613T1 (de) | 2002-09-05 | 2003-09-05 | Modifizierte therapeutische mittel |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20060241048A1 (de) |
| EP (1) | EP1542730B1 (de) |
| AT (1) | ATE328613T1 (de) |
| AU (1) | AU2003260791A1 (de) |
| CA (1) | CA2536795A1 (de) |
| DE (1) | DE60305940T2 (de) |
| GB (1) | GB0220936D0 (de) |
| WO (1) | WO2004022101A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9614871D0 (en) * | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
| GB0220936D0 (en) * | 2002-09-05 | 2002-10-23 | Adprotech Ltd | Modified therapeutic agents |
| GB0915519D0 (en) | 2009-09-04 | 2009-10-07 | King S College London | Ntithrombotic compounds |
| GB201402267D0 (en) * | 2014-02-10 | 2014-03-26 | Cambridge Entpr Ltd | Antibacterial agents |
| GB202002707D0 (en) * | 2020-02-26 | 2020-04-08 | King S College London | Compositions and methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169933A (en) * | 1988-08-15 | 1992-12-08 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| WO1993022343A1 (en) | 1992-05-01 | 1993-11-11 | The Rockfeller University | Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom |
| US5716614A (en) * | 1994-08-05 | 1998-02-10 | Molecular/Structural Biotechnologies, Inc. | Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier |
| GB9614871D0 (en) * | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
| GB9704519D0 (en) * | 1997-03-05 | 1997-04-23 | Smithkline Beecham Plc | Compounds |
| US7081495B1 (en) | 1998-09-23 | 2006-07-25 | School Of Pharmacy, University Of London | Cationic compounds and their use as macro molecular carriers |
| GB0026924D0 (en) | 2000-11-03 | 2000-12-20 | Univ Cambridge Tech | Antibacterial agents |
| GB0220936D0 (en) * | 2002-09-05 | 2002-10-23 | Adprotech Ltd | Modified therapeutic agents |
-
2002
- 2002-09-05 GB GBGB0220936.9A patent/GB0220936D0/en not_active Ceased
-
2003
- 2003-09-05 WO PCT/GB2003/003867 patent/WO2004022101A1/en not_active Ceased
- 2003-09-05 DE DE60305940T patent/DE60305940T2/de not_active Expired - Lifetime
- 2003-09-05 CA CA002536795A patent/CA2536795A1/en not_active Abandoned
- 2003-09-05 AT AT03793901T patent/ATE328613T1/de not_active IP Right Cessation
- 2003-09-05 US US10/526,808 patent/US20060241048A1/en not_active Abandoned
- 2003-09-05 AU AU2003260791A patent/AU2003260791A1/en not_active Abandoned
- 2003-09-05 EP EP03793901A patent/EP1542730B1/de not_active Expired - Lifetime
-
2010
- 2010-01-15 US US12/688,252 patent/US8455447B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1542730A1 (de) | 2005-06-22 |
| DE60305940D1 (de) | 2006-07-20 |
| DE60305940T2 (de) | 2007-02-01 |
| CA2536795A1 (en) | 2004-03-18 |
| WO2004022101A1 (en) | 2004-03-18 |
| GB0220936D0 (en) | 2002-10-23 |
| AU2003260791A1 (en) | 2004-03-29 |
| US20060241048A1 (en) | 2006-10-26 |
| US8455447B2 (en) | 2013-06-04 |
| US20110086808A1 (en) | 2011-04-14 |
| EP1542730B1 (de) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20044039L (no) | Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider. | |
| BRPI0718688A8 (pt) | Composições de baixa irritação e métodos para preparar as mesmas | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| ECSP088508A (es) | Antagonistas de neuropilina | |
| ATE350409T1 (de) | Ampholytisches copolymer und dessen verwendung | |
| MA28752B1 (fr) | Derives de sulfonamides, leur preparation et leur application en therapeutique | |
| CY1116169T1 (el) | Συνθεσεις και μεθοδοι χρησης πεπτιδιων προνησιδιων και αναλογων εξ' αυτων | |
| BRPI0809583A2 (pt) | polipeptídeos fgf-21 modificados e seus usos | |
| ECSP088463A (es) | Antagonistas de activina-actriia y usos para promover el crecimiento óseo | |
| BRPI0507118A (pt) | polipeptìdeos de interferon humano modificado e seus usos | |
| BR0113798A (pt) | Derivados de resorcinol | |
| BR0107691A (pt) | Sapogeninas substituìdas e seu uso | |
| DK1792927T3 (da) | Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens | |
| CR8766A (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
| CY1112682T1 (el) | Ενεργες παραλλαγες της πρωτεϊνης προσδεσης il-18 και ιατρικες χρησεις αυτων | |
| DK1328297T3 (da) | Funktionen af en haptoglobin-hæmoglobin receptor og anvendelser heraf | |
| DK1469843T3 (da) | Komposition til farmaceutisk eller diætetisk anvendelse til at bekæmpe hårtab | |
| DK1228097T3 (da) | Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge | |
| ITRM20030363A1 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse. | |
| PT1282418E (pt) | Utilizacao de derivados pirazolo para o tratamento da infertilidade | |
| DE60305940D1 (de) | Modifizierte therapeutische mittel | |
| FR2870846B1 (fr) | Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique | |
| FR2806722B1 (fr) | Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique | |
| ATE348886T1 (de) | Auf zelluläre ziele gerichtete verbindungen | |
| DE502004012272D1 (de) | Kosmetisches oder therapeutisches kombinationspraparat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1542730 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |